Loteprednol

Loteprednol etabonate
Systematic (IUPAC) name
Chloromethyl 17-ethoxycarbonyloxy-11-hydroxy-10,13-dimethyl-3-oxo-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthrene-17-carboxylate
Clinical data
AHFS/Drugs.com Micromedex Detailed Consumer Information
MedlinePlus a606003
Pregnancy
category
  • US: C (Risk not ruled out)
Legal status
Identifiers
CAS Number 82034-46-6 YesY
ATC code S01BA14
PubChem CID 444025
IUPHAR/BPS 7085
DrugBank DB00873 N
ChemSpider 392049 N
UNII Z8CBU6KR16 N
KEGG D01689 YesY
ChEMBL CHEMBL1201389 N
Chemical data
Formula C24H31ClO7
Molar mass 466.951 g/mol
 NYesY (what is this?)  (verify)

Loteprednol (as the ester loteprednol etabonate) is a corticosteroid used in ophthalmology. Marketed by Bausch and Lomb as Lotemax in the U.S., ocular applications for this drug include the treatment of inflammation of the eye due to allergies (according to the prescription information sheet), as well as chronic forms of keratitis (e.g.: adenoviral and Thygeson’s keratitis), vernal keratoconjunctivitis, pingueculitis, and episcleritis. The drug has little or no effect on intraocular pressure.

See also

References



Español

This article is issued from Wikipedia - version of the Friday, December 18, 2015. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.